Epidemiological evolution of COVID-19 in Brazil and worldwide

Detalhes bibliográficos
Autor(a) principal: Sousa, Grasyele Oliveira
Data de Publicação: 2020
Outros Autores: Sales, Bruno Nascimento, Rodrigues, Aldenora Maria Ximenes, Rocha, Gabriel Mauriz de Moura, Oliveira, Guilherme Antônio Lopes de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
DOI: 10.33448/rsd-v9i7.4653
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/4653
Resumo: Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.
id UNIFEI_5bd7b9e995df85e23cf44a43e877d9c7
oai_identifier_str oai:ojs.pkp.sfu.ca:article/4653
network_acronym_str UNIFEI
network_name_str Research, Society and Development
spelling Epidemiological evolution of COVID-19 in Brazil and worldwideEvolución epidemiológica de COVID-19 en Brasil y en todo el mundoEvolução epidemiológica da COVID-19 no Brasil e no mundoCoronavírusPandemiaEpidemiologiaMortalidade.CoronavirusPandemiaEpidemiologíaMortalidad.CoronavirusPandemicEpidemiologyMortality.Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.Objetivo: analizar la evolución epidemiológica de COVID-19 en Brasil en correlación con el escenario mundial actual. Metodología: este es un estudio epidemiológico analítico y documental con un enfoque cuantitativo y descriptivo de datos secundarios del COVID-19 del Boletín Epidemiológico Especial número 15 del Ministerio de Salud de Brasil sobre la situación epidemiológica hasta el 8 de mayo de 2020. Resultados: Estados Unidos lidera en número de casos confirmados 1.318.787 (33%) y muertes 78.503 (28%) en el mundo. Brasil, ocupa el octavo lugar con 145,328 (4%) de los casos confirmados de COVID-19, su letalidad es de 6.8% y la mortalidad es de 46.6 por 1,000,000 de habitantes. En 2020, se registraron 107.895 hospitalizaciones por síndrome respiratorio agudo severo en Brasil, de las cuales 27.086 (25%) fueron casos confirmados de COVID-19 y 7.514 (28%) murieron, con personas de 60 años o más 5.697 (69%) de los casos y enfermedades cardíacas y diabetes fueron los grupos de riesgo que se destacaron considerablemente en las muertes de ancianos. Conclusión: la enfermedad aún no está bajo control, la distancia social y el uso de máscaras son la mejor manera de prevenir la progresión de casos y muertes por COVID-19.Objetivo: analisar a evolução epidemiológica da COVID-19 no Brasil correlacionando ao cenário mundial atual. Metodologia: trata-se de um estudo epidemiológico analítico e documental com abordagem quantitativa e descritiva de dados secundários da COVID-19 do Boletim Epidemiológico Especial número 15 do Ministério da Saúde do Brasil sobre a situação epidemiológica até o dia 08 de maio de 2020.  Resultados: os Estados Unidos lideram em número de casos confirmados 1.318.787 (33%) e óbitos 78.503 (28%) no mundo. O Brasil, ocupa o 8º lugar com 145.328 (4%) dos casos confirmados de COVID-19, a sua letalidade está em 6,8% e a mortalidade é de 46,6 por 1.000.000 de habitantes. Em 2020, registrou-se 107.895 hospitalizações por Síndrome Respiratória Aguda Grave no Brasil, desse total, 27.086 (25%) eram casos confirmados de COVID-19 e 7.514 (28%) evoluíram para óbito, sendo as pessoas com 60 anos ou mais 5.697 (69%) dos casos e as cardiopatias e o diabetes os grupos de risco que destacaram-se consideravelmente nos óbitos dos idosos. Conclusão: a doença ainda não está sob controle, o distanciamento social e o uso de máscaras são a melhor forma de evitar a progressão de casos e mortes por COVID-19.Research, Society and Development2020-05-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/465310.33448/rsd-v9i7.4653Research, Society and Development; Vol. 9 No. 7; e630974653Research, Society and Development; Vol. 9 Núm. 7; e630974653Research, Society and Development; v. 9 n. 7; e6309746532525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/4653/4022Copyright (c) 2020 Gabriel Mauriz de Moura Rocha, Aldenora Maria Ximenes Rodrigues, Bruno Nascimento Sales, Grasyele Oliveira Sousa, Guilherme Antônio Lopes de Oliveirainfo:eu-repo/semantics/openAccessSousa, Grasyele OliveiraSales, Bruno NascimentoRodrigues, Aldenora Maria XimenesRocha, Gabriel Mauriz de MouraOliveira, Guilherme Antônio Lopes de2020-08-20T18:05:03Zoai:ojs.pkp.sfu.ca:article/4653Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:28:26.086822Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Epidemiological evolution of COVID-19 in Brazil and worldwide
Evolución epidemiológica de COVID-19 en Brasil y en todo el mundo
Evolução epidemiológica da COVID-19 no Brasil e no mundo
title Epidemiological evolution of COVID-19 in Brazil and worldwide
spellingShingle Epidemiological evolution of COVID-19 in Brazil and worldwide
Epidemiological evolution of COVID-19 in Brazil and worldwide
Sousa, Grasyele Oliveira
Coronavírus
Pandemia
Epidemiologia
Mortalidade.
Coronavirus
Pandemia
Epidemiología
Mortalidad.
Coronavirus
Pandemic
Epidemiology
Mortality.
Sousa, Grasyele Oliveira
Coronavírus
Pandemia
Epidemiologia
Mortalidade.
Coronavirus
Pandemia
Epidemiología
Mortalidad.
Coronavirus
Pandemic
Epidemiology
Mortality.
title_short Epidemiological evolution of COVID-19 in Brazil and worldwide
title_full Epidemiological evolution of COVID-19 in Brazil and worldwide
title_fullStr Epidemiological evolution of COVID-19 in Brazil and worldwide
Epidemiological evolution of COVID-19 in Brazil and worldwide
title_full_unstemmed Epidemiological evolution of COVID-19 in Brazil and worldwide
Epidemiological evolution of COVID-19 in Brazil and worldwide
title_sort Epidemiological evolution of COVID-19 in Brazil and worldwide
author Sousa, Grasyele Oliveira
author_facet Sousa, Grasyele Oliveira
Sousa, Grasyele Oliveira
Sales, Bruno Nascimento
Rodrigues, Aldenora Maria Ximenes
Rocha, Gabriel Mauriz de Moura
Oliveira, Guilherme Antônio Lopes de
Sales, Bruno Nascimento
Rodrigues, Aldenora Maria Ximenes
Rocha, Gabriel Mauriz de Moura
Oliveira, Guilherme Antônio Lopes de
author_role author
author2 Sales, Bruno Nascimento
Rodrigues, Aldenora Maria Ximenes
Rocha, Gabriel Mauriz de Moura
Oliveira, Guilherme Antônio Lopes de
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Sousa, Grasyele Oliveira
Sales, Bruno Nascimento
Rodrigues, Aldenora Maria Ximenes
Rocha, Gabriel Mauriz de Moura
Oliveira, Guilherme Antônio Lopes de
dc.subject.por.fl_str_mv Coronavírus
Pandemia
Epidemiologia
Mortalidade.
Coronavirus
Pandemia
Epidemiología
Mortalidad.
Coronavirus
Pandemic
Epidemiology
Mortality.
topic Coronavírus
Pandemia
Epidemiologia
Mortalidade.
Coronavirus
Pandemia
Epidemiología
Mortalidad.
Coronavirus
Pandemic
Epidemiology
Mortality.
description Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.
publishDate 2020
dc.date.none.fl_str_mv 2020-05-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/4653
10.33448/rsd-v9i7.4653
url https://rsdjournal.org/index.php/rsd/article/view/4653
identifier_str_mv 10.33448/rsd-v9i7.4653
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/4653/4022
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 7; e630974653
Research, Society and Development; Vol. 9 Núm. 7; e630974653
Research, Society and Development; v. 9 n. 7; e630974653
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1822178759639302144
dc.identifier.doi.none.fl_str_mv 10.33448/rsd-v9i7.4653